Published in Obesity and Diabetes Week, October 20th, 2003
M-Biotech President and CEO In Suk Han, PhD, said, "This milestone brings us one step closer to the goal of developing a critically needed innovative way of monitoring the glucose levels of diabetes patients to improve their quality of life."
He continued: "We look forward to accelerating the development of this innovative medical device upon completion of our next round of financing."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week